Filter your search
Point-of-care (POC) diagnostics are used across care settings, from consumers’ homes to bedsides in hospital intensive care units. The point-of-care diagnostic industry marks the shift from curative to predictive medicine, and globally millions of dollars are spent annually on the market. Point-of-care diagnostics represent the middle ground between rapid testing performed near a patient that is low in complexity, and the advanced technology that uses clinical molecular diagnostics. To this end, point-of-care diagnostics seek rapid results with an ease-of-use operation. This collection of reports provides insight into the point-of-care diagnostics market’s developments, like its targeting of infectious diseases as initial objectives. Kalorama Information has routinely profiled the clinical POC diagnostics market in its product development trends, market opportunities, and current and future sales in several product categories. Our reports are leading resources for industry professionals interested in molecular POC diagnostics, retail clinic diagnostics, and physician office laboratory (POL) markets worldwide.
- $2,800.00 – $5,600.00Mexico IVD Market Analysis In Mexico, there is a growing demand for new technologies in the laboratory sector and, as government and private hospital budgets increase, the market is expected to see an increase in demand for high-tech equipment and consumables. Mexico IVD Market Analysis focuses on the in vitro diagnostic (IVD) discipline including revenue […]July 25, 2017$3,360.00 – $6,720.00Indonesia IVD Market Analysis Indonesia IVD Market Analysis provides market segmentation, discusses healthcare and regulatory trends, and examines in vitro diagnostics (IVD) manufacturers participating in Indonesia’s marketplace. The following revenue information for 2017-2022 Indonesian IVD market segments is provided: Rapid Tests for Infectious Diseases by Category (HIV; STDs; Hepatitis [HBV, HCV, etc.]; Other [includes Dengue, […]July 19, 2017$2,800.00 – $5,600.00The POC market is considered evolving with growthopportunity.  Developing and developedmarkets alike have room to grow due to an aging population worldwide. Key companies such as Roche, LifeScan,Abbott, and Alere will likely maintain leading positions in the market throughcontinued product innovation and strategic alliances and mergers.  This report profiles 50 companies that will determine the […]May 4, 2017$3,196.00 – $6,392.00The World Market for Point of Care (POC) Diagnostics World Market for Point of Care (POC) Diagnostics examines the worldwide market for POC, including the following information: Worldwide POC Test Market for every significant segment of POC Testing from 2014-2021; Worldwide POC Market Share of top manufacturers, 2016; Professional and Self-testing, 2016; Worldwide POC professional […]February 3, 2017$2,396.00 – $4,792.00IVD in the Middle East (Egypt, Turkey, Saudi Arabia, United Arab Emirates, Israel, Jordan, Other Mideast) In vitro diagnostic (IVD) companies are casting their nets in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. The Middle East is an underserved […]October 4, 2016This Kalorama Information report, The Worldwide Market for In Vitro Diagnostic Tests, represents the 10th edition of this comprehensive look at the IVD industry. At 1,600 pages report provides market size estimates and projections for the entirety of the clinical diagnostics testing market. It also profiles hundreds of competitors, notes significant acquisitions and other […]August 22, 2016$6,000.00 – $12,000.00This combined report offering allows customers of Kalorama research to have two titles, combining Kalorama’s authoritative volume covering the entire world POC market with its more focused report on molecular POC systems. The World Market for Point of Care (POC) Diagnostics presents current analysis of the POC diagnostics industry and the role it plays in […]July 28, 2016$3,360.00 – $6,720.00Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the developing world.bThe Market and Potential for Molecular Point of Care Diagnostics […]February 26, 2016$796.00 – $1,592.00Point of Care (POC) Cholesterol Testing Market Point of Care (POC) Cholesterol Testing Market presents the revenue picture for cholesterol testing performed at or near the site where the patient is located. The following data regarding the POC cholesterol market are provided: world POC cholesterol testing revenue estimates, 2012-2020; POC cholesterol self-testing revenue estimates, 2015 […]January 26, 2016This Kalorama Information In Vitro Diagnostics (IVD) Market Bundle represents three reports, as published in 2015. These reports, representing over 2,000 pages of market information, delve into some of the fastest-growing and most critical areas of clinical diagnostics: cancer diagnostics, molecular assays and systems, and infectious disease tests. Together, these three in vitro diagnostic areas […]January 22, 2016